Search
for
Sort by
Research 30 of 910
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Upaya Pemacuan Stok Ikan Bilih (Mystacoleucus padangensis) di Danau Singkarak
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Drug-Induced Alopecia Areata From Upadacitinib
- Urokinase plasminogen activator (uPA) is a positive regulator of outer root sheath keratinocyte proliferation
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Upadacitinib for the treatment of refractory alopecia areata in pediatric patients: A retrospective study
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Long-term Efficacy and Safety of Upadacitinib in the Treatment of Alopecia Areata: A Retrospective Study
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib